The effect of infliximab on bone metabolism markers in patients with rheumatoid arthritis.

@article{Torikai2006TheEO,
  title={The effect of infliximab on bone metabolism markers in patients with rheumatoid arthritis.},
  author={Eiji Torikai and Yasunori Kageyama and M Takahashi and Makoto Suzuki and Tetsuya Ichikawa and Tetsuyuki Nagafusa and Akira Nagano},
  journal={Rheumatology},
  year={2006},
  volume={45 6},
  pages={761-4}
}
OBJECTIVE The aim of this study was to evaluate urinary excretion of N-telopeptide of type I collagen (NTX) and deoxypyridinoline (DPD), markers of bone resorption, and serum bone alkaline phosphatase (BAP) level, a marker of bone formation and an early marker of osteoblast differentiation, in patients with rheumatoid arthritis (RA) treated with infliximab. METHODS Seventeen male and female patients (age 60.7+/-2.53 yr; mean disease duration 12.9+/-3.01 yr; Steinbrocker's class II-IV) with RA… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Similar Papers

Loading similar papers…